TAP Pharmaceutical Products
From Wikipedia, the free encyclopedia
TAP Pharmaceutical Products was formed in 1977 as a joint venture between the two global pharmaceutical companies, Abbott Laboratories and Takeda Pharmaceutical Co. The company markets PrevacidĀ® (lansoprazole) and Lupron DepotĀ® (leuprolide acetate for depot suspension), both leaders in their classes.